...
机译:在控制的MDMA管理后,人类汗液中的MDMA和代谢物的处置
Allan J. Barnes,1 Bruno S. De Martinis,3 David A. Gorelick,2 Robert S. Goodwin,1 Erin A. Kolbrich,1,4 and Marilyn A. Huestis1*1 Chemistry and Drug Metabolism and 2 Office of Scientific Director, Intramural Research Program, National Institute on Drug Abuse, NIH, Baltimore MD, 3 Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Center of Legal Medicine, Ribeirão Preto, Brazil, 4 Institute of Forensic Sciences, Medical Examiners Office/Crime Investigation Lab, Dallas County, Dallas, Texas.* Address correspondence to this author at: Biomedical Research Center, 251 Bayview Blvd. Suite 200 Room 05A-721, Baltimore, MD 21224. E-mail mhuestis@intra.nida.nih.gov.Received September 2, 2008, accepted December 22, 2008.Previously published online at DOI: 10.1373/clinchem.2008.117093,;
机译:在控制的MDMA给药后,人类汗液中的MDMA和代谢物的处置。
机译:在控制的MDMA管理后,人类汗液中MDMA和代谢物的处置
机译:在控制性口服MDMA给药后,痰液中的MDMA和代谢物分布。
机译:5G MDMA蜂窝系统中用于下行链路功率控制的系统容量和收敛速率评估
机译:(+,-)-MDMA神经毒性破坏(+)-3,4-亚甲二氧基甲基苯丙胺(MDMA)的歧视性刺激作用:氟西汀的保护。
机译:在控制的MDMA管理后人类汗液中的MDMA和代谢物的处置
机译:在控制的MDMA管理后,人类汗液中MDMA和代谢物的处置